NVAX NOVAVAX
Permanent stock page ↗Health Care · Russell 2000
Next earnings: not announced yet
What 10 analyst firms say about NOVAVAX: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
9 rated views · 10 analyst/firm records · 10 firms
Radar score
- Russell 2000 · Top Picks · 6MBelow the Radar threshold of 8017
- Russell 2000 · Safest consensus · 6MBelow the Radar threshold of 8018
Recent analyst activity · last 90 days
Our tracked history has 3 reports on NVAX from 3 analyst firms in the last 90 days (10 firms in the past year).
Comparing each firm's latest target with its previous one: 1 raised its price target, 1 left it unchanged and 1 has its first observed target in the past year.
No firm's latest available rating differs from its previous one.
Latest observed target change: TD Cowen raised its target from $9.00 (set 6 May 2026) to $11.00 on 29 Oct 2026.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| B Riley Securities | Mayank Mamtani | Buy | 7 Aug 2026 | 18.00 USD |
| BTIG | Thomas Shrader | Buy | 11 Jun 2026 | 19.00 USD |
| Cantor Fitzgerald | Pete Stavropoulos | Buy | 27 Oct 2026 | 18.00 USD |
| Citigroup | Geoff Meacham | Sell | 15 Oct 2026 | 8.00 USD |
| H.C. Wainwright | Sean Lee | Buy | 27 Feb 2026 | 16.00 USD |
| Jefferies | Roger Song | Buy | 2 Mar 2026 | 25.00 USD |
| JPMorgan | Anupam Rama | Sell | 18 Nov 2025 | 6.00 USD |
| TD Cowen | Chris Lobianco | Hold | 29 Oct 2026 | 11.00 USD |
| Weiss Ratings | Unnamed analyst | — | 4 Aug 2026 | — |
| Data feed RESEARCH | Research Team | Hold | 6 Aug 2026 | 12.00 USD |
Partial coverage · checked 6 Nov (6 Nov 2026, 05:56 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.